| 12/11/24 | 16:05:56 | 12 Nov 2024 | | Form 8 (OPD) (Tissue Regenix Group Plc) |
| 12/11/24 | 08:46:56 | 12 Nov 2024 | | Form 8.5 (EPT/NON-RI) |
| 11/11/24 | 09:17:53 | 11 Nov 2024 | | Form 8.5 (EPT/NON-RI) |
| 07/11/24 | 09:59:09 | 7 Nov 2024 | | Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC |
| 06/11/24 | 13:37:01 | 6 Nov 2024 | | Form 8.3 - Tissue Regenix Group PLC |
| 06/11/24 | 08:52:55 | 6 Nov 2024 | | Form 8.5 (EPT/NON-RI) |
| 05/11/24 | 14:24:42 | 5 Nov 2024 | | Form 8.3 - Tissue Regenix Group PLC |
| 05/11/24 | 11:32:44 | 5 Nov 2024 | | Form 8.5 (EPT/NON-RI) |
| 04/11/24 | 16:36:48 | 4 Nov 2024 | | Response to media speculation |
| 10/09/24 | 07:00:04 | 10 Sept 2024 | | Interim results for the six months ended 30 June |
| 21/08/24 | 07:00:08 | 21 Aug 2024 | | Confirmation of results |
| 18/07/24 | 15:52:16 | 18 Jul 2024 | | Grant of share options |
| 16/07/24 | 07:00:03 | 16 Jul 2024 | | Half-Year Trading Update |
| 03/07/24 | 13:16:50 | 3 Jul 2024 | | Holding(s) in Company |
| 24/06/24 | 16:12:50 | 24 Jun 2024 | | Holding(s) in Company |
| 18/06/24 | 17:15:33 | 18 Jun 2024 | | Exercise of Options, Director Dealing and TVR |
| 14/06/24 | 07:00:06 | 14 Jun 2024 | | Building purchase |
| 25/04/24 | 14:27:54 | 25 Apr 2024 | | Result of AGM |
| 05/04/24 | 15:52:05 | 5 Apr 2024 | | Holding(s) in Company |
| 19/03/24 | 07:00:08 | 19 Mar 2024 | | Final results for the year ended 31 December 2023 |
| 01/03/24 | 07:00:12 | 1 Mar 2024 | | Notice of Results |
| 06/02/24 | 07:00:09 | 6 Feb 2024 | | First EU shipment & new distributor agreements |
| 29/01/24 | 15:02:07 | 29 Jan 2024 | | Holding(s) in Company |
| 25/01/24 | 07:00:03 | 25 Jan 2024 | | Trading update for 2023 |
| 23/01/24 | 17:24:54 | 23 Jan 2024 | | 2023 LTIP Grant |
| 22/11/23 | 16:36:05 | 22 Nov 2023 | | Holding(s) in Company |
| 30/10/23 | 07:00:13 | 30 Oct 2023 | | HPRA approval & distribution agreement in Spain |
| 15/09/23 | 16:30:00 | 15 Sept 2023 | | Director/PDMR Shareholding |
| 05/09/23 | 07:01:02 | 5 Sept 2023 | | New sports medicine product launch |
| 05/09/23 | 07:00:04 | 5 Sept 2023 | | Interim results |
| 31/08/23 | 13:45:02 | 31 Aug 2023 | | Exercise of Options and Total Voting Rights |
| 21/08/23 | 07:00:05 | 21 Aug 2023 | | Notice of interim results |
| 17/07/23 | 07:00:03 | 17 Jul 2023 | | Half-Year Trading Update |
| 10/07/23 | 07:00:05 | 10 Jul 2023 | | Distribution agreement for OrthoPure® XT in the UK |
| 25/05/23 | 07:00:09 | 25 May 2023 | | Distribution agreement with Australian Allografts |
| 09/05/23 | 12:00:04 | 9 May 2023 | | Holding(s) in Company |
| 27/04/23 | 12:35:58 | 27 Apr 2023 | | Result of AGM, Share Reorganisation &TVR |
| 18/04/23 | 07:00:05 | 18 Apr 2023 | | Proposed Share Reorganisation Timetable |
| 05/04/23 | 07:00:05 | 5 Apr 2023 | | CEO and CFO Share Purchases |
| 30/03/23 | 07:00:08 | 30 Mar 2023 | | Holding(s) in Company |
| 21/03/23 | 07:00:05 | 21 Mar 2023 | | Final results for the year ended 31 December 2022 |
| 06/03/23 | 07:00:04 | 6 Mar 2023 | | Notice of results and Investor presentation |
| 31/01/23 | 07:01:02 | 31 Jan 2023 | | Trading update for 2022 |
| 31/01/23 | 07:00:11 | 31 Jan 2023 | | Change of Adviser |
| 18/01/23 | 10:06:02 | 18 Jan 2023 | | Holding(s) in Company |
| 18/01/23 | 07:00:04 | 18 Jan 2023 | | Chinese distribution agreement for OrthoPure® XT |
| 07/12/22 | 07:00:06 | 7 Dec 2022 | | Product launch in dCELL® division |
| 22/11/22 | 07:00:07 | 22 Nov 2022 | | Distribution agreement - OrthoPure® XT in Germany |
| 14/11/22 | 18:05:45 | 14 Nov 2022 | | Holding(s) in Company |
| 07/11/22 | 14:35:49 | 7 Nov 2022 | | Holding(s) in Company |
